Literature DB >> 22253456

Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.

Anneleen Daniels1, Dominik Linz, Marc van Bilsen, Hartmut Rütten, Thorsten Sadowski, Sven Ruf, Hans-Paul Juretschke, Claudia Neumann-Haefelin, Chantal Munts, Ger J van der Vusse, Frans A van Nieuwenhoven.   

Abstract

AIMS: Type 2 diabetes mellitus (DM) leads to cardiac dysfunction irrespective of hypertension and coronary artery disease; this is called diabetic cardiomyopathy. Here, we investigated the severity of diabetic cardiomyopathy and myocardial remodelling in aged Zucker diabetic fatty (ZDF) rats. METHODS AND
RESULTS: Body weight, blood glucose and glycated haemoglobin (Hb(A1c)) levels, and urinary albumin excretion were monitored regularly in ZDF rats (n = 19) and control littermates (n = 19) up to age 45 weeks. ZDF rats were severely diabetic during the entire study period and demonstrated decreased body and heart weights at sacrifice. Left ventricular (LV) function was determined using magnetic resonance imaging (MRI) at age 44 weeks and revealed similar LV ejection fraction and cardiac output index in control and ZDF rats, indicating preserved systolic function. LV pressure characteristics assessed at age 45 weeks showed significant, but mild elevations of LV end-diastolic pressure (+45%) and relaxation time constant Tau (+54%) in ZDF rats, indicating diastolic dysfunction. Histological analyses revealed a significantly increased LV collagen content (+50%), but no cardiomyocyte hypertrophy in ZDF rats.
CONCLUSION: The present study clearly shows that long term, severe DM in 45-week-old ZDF rats resulted in relatively mild impairment of diastolic LV function, whereas systolic function was well preserved. These data do not support the notion that diabetes per se is a critical factor in the induction of a clinically relevant degree of cardiac dysfunction. Co-morbidities such as hypertension and coronary artery disease probably have larger impacts on myocardial function in diabetic individuals.

Entities:  

Mesh:

Year:  2012        PMID: 22253456     DOI: 10.1093/eurjhf/hfr166

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  29 in total

1.  Effect and mechanisms of zinc supplementation in protecting against diabetic cardiomyopathy in a rat model of type 2 diabetes.

Authors:  Ying Lu; Ya Liu; Hongyan Li; Xue Wang; Wenjie Wu; Lichao Gao
Journal:  Bosn J Basic Med Sci       Date:  2015-02-05       Impact factor: 3.363

2.  A mini-network balance model for evaluating the progression of cardiovascular complications in Goto-Kakizaki rats.

Authors:  Hao Jiang; Yu-Hao Wang; Chun-Xiang Wei; Xue Zhang; Hao-Chen Liu; Xiao-Quan Liu
Journal:  Acta Pharmacol Sin       Date:  2017-01-02       Impact factor: 6.150

Review 3.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

4.  Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats.

Authors:  Marie-Soleil Beaudoin; Christopher G R Perry; Alicia M Arkell; Adrian Chabowski; Jeremy A Simpson; David C Wright; Graham P Holloway
Journal:  J Physiol       Date:  2014-03-17       Impact factor: 5.182

Review 5.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

6.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

7.  Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.

Authors:  Rakeshwar S Guleria; Amar B Singh; Irina T Nizamutdinova; Tatiana Souslova; Amin A Mohammad; Jonathan A Kendall; Kenneth M Baker; Jing Pan
Journal:  J Mol Cell Cardiol       Date:  2013-02-05       Impact factor: 5.000

8.  Matrix Metalloproteinases and Their Role in Mechanisms Underlying Effects of Quercetin on Heart Function in Aged Zucker Diabetic Fatty Rats.

Authors:  Barbora Boťanská; Monika Barteková; Kristína Ferenczyová; Mária Fogarassyová; Lucia Kindernay; Miroslav Barančík
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

9.  Alterations in glutathione redox metabolism, oxidative stress, and mitochondrial function in the left ventricle of elderly Zucker diabetic fatty rat heart.

Authors:  Haider Raza; Annie John; Frank C Howarth
Journal:  Int J Mol Sci       Date:  2012-11-30       Impact factor: 5.923

10.  Myocardial impulse propagation is impaired in right ventricular tissue of Zucker diabetic fatty (ZDF) rats.

Authors:  Kristine Boisen Olsen; Lene Nygaard Axelsen; Thomas Hartig Braunstein; Charlotte Mehlin Sørensen; Claus B Andersen; Thorkil Ploug; Niels-Henrik Holstein-Rathlou; Morten Schak Nielsen
Journal:  Cardiovasc Diabetol       Date:  2013-01-17       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.